Bed Bath & Beyond Résultats passés
Passé contrôle des critères 0/6
Les bénéfices de Bed Bath & Beyond ont diminué à un taux annuel moyen de -48%, tandis que le secteur Specialty Retail a vu ses bénéfices augmenter de en baisse à 1.9% par an. Les revenus ont augmenté de en baisse à un taux moyen de 21.7% par an.
Informations clés
-48.02%
Taux de croissance des bénéfices
-47.26%
Taux de croissance du BPA
| Specialty Retail Croissance de l'industrie | 26.64% |
| Taux de croissance des recettes | -21.74% |
| Rendement des fonds propres | -30.18% |
| Marge nette | -5.76% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour de l'analyse • May 05
BBBY: Core Business Inflection And SKU Consolidation Will Support Future Repricing
Narrative Update Analysts have maintained their average $7.00 price target on Bed Bath & Beyond, with recent research citing mixed signals. Higher projected revenue growth and a very high future P/E multiple are being weighed against materially lower margin assumptions and ongoing execution uncertainty.Seeking Alpha • Apr 29
Bed Bath & Beyond: Still Unprofitable, Still Burning Through Cash
Summary Bed Bath & Beyond reported another quarter of negative GAAP net losses, heavy dilution, and cash burn. BBBY's revenue grew 7% year-over-year in the first quarter, aided by acquisitions, but gross margin declined 117 basis points to 23.9%. Recent purchases, including The Container Store and F9 Brands assets, are expected to drive revenue through 2026. BBBY is targeting $60 million in cost reductions for 2026, yet dilution and negative operating cash flow overshadow near-term growth prospects. Read the full article on Seeking AlphaMise à jour de l'analyse • Apr 21
BBBY: Core Business Inflection And SKU Consolidation Will Drive Future Upside
Analysts have trimmed their average price targets for Bed Bath & Beyond to a range of about $7 to $8 from prior levels near $10 to $13, citing a mix of sequential improvement in the core business, cautious views on the execution of internal initiatives, and a valuation reset based on updated EBITDA assumptions. Analyst Commentary Recent research updates highlight that price targets for Bed Bath & Beyond have been pulled back into the high single digits, with analysts pointing to a mix of operational progress and ongoing execution risk.Mise à jour de l'analyse • Apr 07
BBBY: SKU Consolidation And Core Business Inflection Will Support Durable Turnaround
Analysts have trimmed Bed Bath & Beyond's average price target to a range anchored around $7 to $8. This reflects cautious views on execution risks even as they point to early signs of improvement in the core business, including SKU consolidation progress and steadier online trends.
Mise à jour de l'analyse • Mar 23
BBBY: Website Momentum And SKU Consolidation Will Support Multiyear Turnaround
Analysts have trimmed their average price target for Bed Bath & Beyond by $0.40. They are tying the shift to mixed Q4 takeaways, where improving core trends and SKU consolidation are being weighed against lower margin expectations and ongoing uncertainty around the multiyear turnaround plan.Mise à jour de l'analyse • Mar 09
BBBY: Lemonis Leadership And SKU Consolidation Will Support Renewed Core Business Momentum
Analysts have trimmed their average price target on Bed Bath & Beyond to a range around $7 to $8, reflecting updated P/E assumptions and caution around execution, even as they point to improving website trends and early traction from internal initiatives such as SKU consolidation. Analyst Commentary Recent research updates show that bearish analysts are trimming price targets even as they acknowledge some operational progress in the core business and on initiatives like SKU consolidation.Mise à jour de l'analyse • Feb 23
BBBY: Website Momentum And 2027 EBITDA Outlook Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Bed Bath & Beyond from $10.90 to $9.80, tying the lower target to a reduced revenue outlook and higher assumed discount rate, partly balanced by expectations for slightly stronger profit margins and a higher future P/E multiple. Analyst Commentary Recent Street research highlights a mix of optimism and caution around Bed Bath & Beyond, with valuation expectations reset lower even as some early signs in the core business draw interest.Mise à jour de l'analyse • Feb 09
BBBY: Leadership Consolidation Under Lemonis Will Support A More Bullish Outlook
Analysts have adjusted their price target on Bed Bath & Beyond to US$7.00, reflecting small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall fair value view unchanged at US$7.00. What's in the News On December 30, 2025, Bed Bath & Beyond's Board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026.Mise à jour de l'analyse • Jan 25
BBBY: Higher US$8 Outlook And Buybacks Will Shape A Cautious Fairly Valued Path
Narrative Update: Bed Bath & Beyond Analyst Price Target Shift Analysts have lifted their 12 month price target on Bed Bath & Beyond to US$8 from US$5, citing refreshed post earnings models that reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary highlights that even with the price target increase to US$8, some research views remain cautious.Article d'analyse • Jan 23
Revenues Not Telling The Story For Bed Bath & Beyond, Inc. (NYSE:BBBY) After Shares Rise 31%
Those holding Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares would be relieved that the share price has rebounded 31% in...Mise à jour de l'analyse • Jan 11
BBBY: Earnings Refit And Buyback Activity Set A Cautious Path Forward
Analysts lifted their price target on Bed Bath & Beyond to US$8.00 from US$5.00, citing updated earnings assumptions that reflect changes to fair value, discount rate, revenue growth, profit margin and future P/E expectations. Analyst Commentary While the updated price target of US$8.00 reflects refreshed earnings assumptions, bearish analysts still frame the stock as a higher risk proposition rather than a clear upside story.Mise à jour de l'analyse • Dec 14
BBBY: Margin Gains And Buyback Support Brighter Outlook Ahead
Analysts have raised their price target on Bed Bath & Beyond to $8 from $5, citing updated post-earnings models that reflect slightly higher profit margin expectations despite more modest projected revenue growth and a higher assumed future valuation multiple. Analyst Commentary Bearish analysts acknowledged that the higher price target reflects improved margin visibility following the latest earnings update, but they emphasized that the new $8 objective still implies limited upside from current levels.Article d'analyse • Nov 02
Some Bed Bath & Beyond, Inc. (NYSE:BBBY) Shareholders Look For Exit As Shares Take 36% Pounding
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders won't be pleased to see that the share price has had a very rough...Article d'analyse • Oct 31
Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders are probably feeling a little disappointed, since its shares fell...Article d'analyse • Sep 09
Bed Bath & Beyond, Inc.'s (NYSE:BBBY) Shares Climb 31% But Its Business Is Yet to Catch Up
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares have continued their recent momentum with a 31% gain in the last month...Mise à jour de l'analyse • Aug 07
E-commerce And Luxury Retail Trends Will Unlock Value
The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples. What's in the News Beyond, Inc.Article d'analyse • Aug 05
Health Check: How Prudently Does Beyond (NYSE:BYON) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d'analyse • Jul 09
Revenues Not Telling The Story For Beyond, Inc. (NYSE:BYON) After Shares Rise 27%
Despite an already strong run, Beyond, Inc. ( NYSE:BYON ) shares have been powering on, with a gain of 27% in the last...Article d'analyse • May 13
What Beyond, Inc.'s (NYSE:BYON) 29% Share Price Gain Is Not Telling You
Beyond, Inc. ( NYSE:BYON ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last...Seeking Alpha • Apr 22
Beyond: Liberation Day Could Be A Disaster For Margins
Summary BYON faces severe financial distress with an 83% stock price drop, negative free cash flow, and liquidity issues set to be exacerbated by tariffs. The company's strategy of acquiring failed brands has not succeeded, leading to asset sales and further liquidity concerns amid recession fears. Fiscal 2024 fourth quarter revenue dropped 21.1% over its year-ago comp, missing estimates, with negative adjusted EBITDA and EPS. Liberation Day tariffs, especially a 145% tariff on Chinese imports, pose significant risks, making BYON a sell due to intense cash burn and uncertainty. Read the full article on Seeking Alpha
Nouvelle analyse • Apr 01
Expense Cuts And Vendor Consolidation Will Streamline Operations
Vendor consolidation and SG&A reductions are poised to enhance profitability and strengthen margins by streamlining operations and costs.Seeking Alpha • Mar 18
Beyond Stock.: Iconic Brands Versus Downward Trending Financials
Summary Beyond, Inc. is in a transition phase, rebranding under Bed Bath & Beyond, and aims to streamline SKUs to improve profitability amid a competitive market. Despite improving net income, Beyond, Inc. reported a 10.6% decline in revenue for 2024, marking the fourth consecutive year of revenue drops. The stock appears cheap with low valuation multiples, but significant risks and ongoing cash flow challenges warrant a cautious "hold" rating. Aggressive cost-cutting and competitive pressures from giants like Amazon and Walmart, along with macroeconomic uncertainties, pose substantial risks to Beyond, Inc.'s turnaround efforts. Read the full article on Seeking AlphaArticle d'analyse • Mar 10
Some Beyond, Inc. (NYSE:BYON) Shareholders Look For Exit As Shares Take 30% Pounding
Beyond, Inc. ( NYSE:BYON ) shares have retraced a considerable 30% in the last month, reversing a fair amount of their...Seeking Alpha • Feb 07
Beyond Inc.: Analysts Overly Pessimistic, Recent Trends Likely To Reverse
Summary Beyond, Inc.'s asset-light model ensures high FCF conversion and positions the company for profitable growth as revenue scales. Leadership under Marcus Lemonis, with equity-based compensation, drives a performance-focused approach, aiming for significant stock price appreciation. Strategic partnerships and private equity investments offer synergies and mispriced optionality, enhancing Beyond's growth potential. Despite past execution missteps and cash burn concerns, market share gains and a stabilizing furniture market present a valuation opportunity. Read the full article on Seeking AlphaArticle d'analyse • Jan 23
After Leaping 43% Beyond, Inc. (NYSE:BYON) Shares Are Not Flying Under The Radar
Beyond, Inc. ( NYSE:BYON ) shares have had a really impressive month, gaining 43% after a shaky period beforehand...Seeking Alpha • Jan 21
Beyond: The Perfect Turnaround Storm Could Be Unfolding
Summary CEO Marcus Lemonis, personally invested $5M, drives a focused KPI-led recovery. Trading at 0.08x EV/revenue, market pricing insolvency, clear turnaround plan, with promising early results. $65M cost cuts mostly realized, paving the path to breakeven FCF by Q3 2025. SKU realignment and targeted marketing address site conversion gaps for revenue lift. Read the full article on Seeking AlphaSeeking Alpha • Nov 13
Is It Beyond Time For Some Changes At Beyond, Inc.?
Summary Executive Chairman Marcus Lemonis has faced criticism for repeated missteps, leading to a 75% decline in BYON shares since he took over. BYON's cash adjusted market cap is down to $135 million, making it both a great acquisition target and a great candidate for a stock buyback. The company's blockchain assets, tZERO and Medici, are significantly more valuable than the retail ops based on current market values and this needs to be communicated to investors. Short interest continues to climb (16.3% of shares), indicating traders expect further declines, but some are expecting a turnaround or acquisition by a strategic investor like Ryan Cohen. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Bed Bath & Beyond gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 1,061 | -61 | 320 | 0 |
| 31 Dec 25 | 1,045 | -85 | 325 | 0 |
| 30 Sep 25 | 1,074 | -145 | 357 | 0 |
| 30 Jun 25 | 1,129 | -202 | 389 | 0 |
| 31 Mar 25 | 1,244 | -225 | 431 | 0 |
| 31 Dec 24 | 1,395 | -259 | 481 | 0 |
| 30 Sep 24 | 1,476 | -339 | 507 | 0 |
| 30 Jun 24 | 1,538 | -341 | 521 | 0 |
| 31 Mar 24 | 1,562 | -371 | 506 | 0 |
| 31 Dec 23 | 1,561 | -308 | 484 | 0 |
| 30 Sep 23 | 1,582 | -164 | 438 | 0 |
| 30 Jun 23 | 1,669 | -138 | 416 | 0 |
| 31 Mar 23 | 1,774 | -56 | 414 | 0 |
| 31 Dec 22 | 1,929 | -37 | 481 | 0 |
| 30 Sep 22 | 2,137 | 9 | 444 | 0 |
| 30 Jun 22 | 2,366 | 74 | 470 | 0 |
| 31 Mar 22 | 2,633 | 118 | 499 | 0 |
| 31 Dec 21 | 2,756 | 134 | 513 | 0 |
| 30 Sep 21 | 2,813 | 126 | 521 | 0 |
| 30 Jun 21 | 2,842 | 134 | 523 | 0 |
| 31 Mar 21 | 2,814 | 127 | 523 | 0 |
| 31 Dec 20 | 2,494 | 91 | 475 | 0 |
| 30 Sep 20 | 2,195 | 42 | 466 | 0 |
| 30 Jun 20 | 1,825 | -25 | 434 | 0 |
| 31 Mar 20 | 1,431 | -95 | 396 | 0 |
| 31 Dec 19 | 1,435 | -62 | 350 | 0 |
| 30 Sep 19 | 1,541 | -139 | 423 | 0 |
| 30 Jun 19 | 1,635 | -154 | 459 | 0 |
| 31 Mar 19 | 1,744 | -193 | 517 | 0 |
| 31 Dec 18 | 1,822 | -205 | 565 | 0 |
| 30 Sep 18 | 1,825 | -253 | 550 | 0 |
| 30 Jun 18 | 1,809 | -207 | 511 | 0 |
| 31 Mar 18 | 1,758 | -151 | 446 | 0 |
| 31 Dec 17 | 1,745 | -107 | 387 | 0 |
| 30 Sep 17 | 1,815 | -11 | 377 | 0 |
| 30 Jun 17 | 1,832 | -13 | 366 | 0 |
| 31 Mar 17 | 1,819 | -7 | 354 | 0 |
| 31 Dec 16 | 1,800 | 13 | 343 | 0 |
| 30 Sep 16 | 1,754 | 10 | 331 | 0 |
| 30 Jun 16 | 1,704 | 11 | 322 | 0 |
| 31 Mar 16 | 1,673 | 13 | 312 | 0 |
| 31 Dec 15 | 1,658 | 2 | 305 | 0 |
| 30 Sep 15 | 1,648 | 4 | 297 | 0 |
| 30 Jun 15 | 1,610 | 7 | 286 | 0 |
Des revenus de qualité: BBBY n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: BBBY n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BBBY n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 48% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de BBBY au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: BBBY n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Specialty Retail ( -1.2% ).
Rendement des fonds propres
ROE élevé: BBBY a un retour sur capitaux propres négatif ( -30.18% ), car il n'est actuellement pas rentable.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/07 23:31 |
| Cours de l'action en fin de journée | 2026/05/07 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Bed Bath & Beyond, Inc. est couverte par 13 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Seth Sigman | Barclays |
| Daniel Kurnos | Benchmark Company |
| Curtis Nagle | BofA Global Research |